miR-128 participates in the pathogenesis of chronic constipation by regulating the p38α/M-CSF inflammatory signaling

Yuntian Hong1,2,3, Xianghai Ren1,2,3,4,5, Weicheng Liu1,2,3,4,5

  • 1Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.

Insights

MicroRNA-128 plays a key role in chronic constipation (CC) by regulating the p38α/M-CSF pathway, influencing colon inflammation and immune microenvironment. This finding offers new therapeutic targets for CC treatment.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Immunology

Background:

  • Chronic constipation (CC) significantly impacts quality of life.
  • MicroRNAs are implicated in the pathogenesis of functional gastrointestinal disorders.

Purpose of the Study:

  • To investigate the molecular mechanism of microRNA-128 (miR-128) in the pathogenesis of chronic constipation.
  • To explore the role of miR-128 in regulating inflammatory responses and the colonic immune microenvironment.

Main Methods:

  • Construction of a murine model of chronic constipation using morphine and rhubarb.
  • miRNA array and bioinformatic analysis to identify miR-128 expression and downstream targets.
  • Coculture assays to assess the effect of miR-128 on macrophage cytokine secretion.

Main Results:

  • The CC model exhibited downregulated miR-128 and upregulated p38α and macrophage colony-stimulating factors (M-CSFs).
  • Elevated inflammatory cytokines (IL-6, TNF-α) and decreased anti-inflammatory cytokines were observed in colonic tissues.
  • Regulation of miR-128 in colonic epithelial cells induced pro-inflammatory cytokine secretion by macrophages.

Conclusions:

  • miR-128 regulates the p38α/M-CSF signaling pathway, contributing to chronic inflammation and immune microenvironment alterations in the colon.
  • The miR-128/p38α/M-CSF axis represents a potential therapeutic target for chronic constipation.

Related Concept Videos